Highlights
The Australian stock market displayed impressive strength with a 1.38% rise in the ASX 200, ending the session at 8,327. The positive momentum can largely be attributed to a surge in the financial sector, which gained significant ground following robust earnings reports from major U.S. banks. With all 11 sectors closing in the green, investor sentiment remained upbeat, boosting confidence across the board.
Leading the charge in terms of individual stock performance was (ASX:NEU) Neuren Pharmaceuticals, which gained 11.54% on the day. The biotech company rebounded strongly from the prior day’s drop and outperformed the broader market. Neuren’s surge followed the news that its U.S. partner, Acadia Pharmaceuticals, applied for approval to market Neuren's Rett syndrome treatment in the European Union.
Another company to see a notable rise was (ASX:Z1P) Zip, which jumped 9.96%. The stock's rally was fueled by positive updates from its U.S. competitor, Sezzle, which raised its revenue outlook, alongside an anticipated benefit for Zip from a weaker Australian dollar in the second quarter. Market analysts, including Citi, suggested these tailwinds could provide strong support in the near term.
Corporate Travel Management (ASX:CTD) also made a significant impression, climbing 6.84%. The stock gained after being included in Morgan Stanley’s ‘key ideas’ list, alongside Life360 (ASX:360), which rose 2.55%. Analysts at Morgan Stanley expressed strong conviction regarding their earnings potential, helping to elevate the stocks of these travel and tech-focused companies.
The financial sector overall saw remarkable results, advancing by 2.56%. A few standout stocks within the group included (ASX:MQG) Macquarie Group, which rose 3.19%, and (ASX:CBA) Commonwealth Bank, which added 2.96% to its value. Other major banks like (ASX:NAB) National Australia Bank, (ASX:ANZ) ANZ, and (ASX:WBC) Westpac all recorded significant advances as well, following strong quarterly earnings reports from U.S. banking giants.
In corporate news, (ASX:BHP) BHP saw a modest gain of 0.5%, announcing a new deal with Canadian miner Lundin Mining to acquire Filo Corp. On the other hand, (ASX:PME) Pro Medicus faced a slight decline of 0.44% following its announcement of a $33 million deal with the University of Kentucky to distribute its Visage products.
The Australian dollar was trading at 61.98 U.S. cents, and investor attention will now turn to upcoming reports, with U.S. firms Morgan Stanley (MS) and Bank of America (BAC) set to release their earnings later tonight. Additionally, upcoming retail sales and unemployment claims reports in the U.S. will be key indicators to watch.